dbio NEWS
& MEDIA
  • Facebook - Black Circle
  • Twitter - Black Circle
  • YouTube - Black Circle

follow US

FOLLOW US

NEWS

RSS Feed
 

Wired Magazine: Silicon Valley Pivots to Pandemic

Jake spoke with Wired journalist Andrew Leonard to talk about the moment he decided to begin an antibody discovery program for COVID-19, our partnership with SwiftScale Bio, and our race to find a treatment within the context of being a small biotech startup merely a stone's throw from Silicon Valley. Read the entire article here.

Jake on CNBC Closing Bell

Jake appeared on CNBC's Closing Bell this afternoon to discuss how far along we are with our antibody treatment development. Watch the segment here.

The Life & Times of 17 year old Computational Immunoengineer Aishani Aatresh

A lover of learning and collaborating, particularly in any scientific or interdisciplinary context beyond the classroom. A strong leader and communicator in a variety of domains. Experienced and interested in the biotech/synthetic biology fields. Moonlighting as an aspiring Renaissance woman. These are the words of Aishani Aatraesh. She is the youngest employee at Distributed Bio and is developing a computational analysis pipeline for Tumbler, a technology that makes and analyzes hundreds of millions of variants of a starting antibody. Listen as Jan, RJ, and Aishani discuss the blessing of growing up with instability, the power of perspective, and how we should frame a global pandemic in our

Cheddar with Nora Ali

Jake appeared on Cheddar news this morning to talk to reporter Nora Ali about our antibody therapeutic success, next steps, and how it will work faster and more efficiently than a vaccine. Watch the segment here.

KRON 4 News

Jake appeared on KRON 4 News to discuss the process of how we engineered the Achilles Heel of the novel coronavirus, and how we are working with the military, the Gates Foundation and other groups to do in vivo testing on hamsters and safety & toxicity studies with Charles River Labs.

TRT feat. Sarah Ives

Sarah Ives appeared on TRT World Newsmakers to give updates on our SARS-CoV-2 antibody treatment.

The Claman Countdown

Jake once again spoke with Liz Claman on Fox Business to officially announce that we have succeeded in engineering a set of antibodies against SARS-CoV-2 and we will be working with the US military and the La Jolla Institute for Immunology backed by CoVIC (the Coronavirus Immunotherapy Consortium) to begin in vivo testing. Watch the clip here.

Science Insider feat. Sarah Ives

Sarah Ives, our Director of Contract Research, was featured on a Science Insider segment focusing on what various scientists around the world are doing to develop COVID-19 vaccines and antibody treatments, called "What Could Be The Fastest Way to End the Coronavirus Crisis?" In this very informative video, Sarah helps rationalize why some companies, including Distributed Bio, have chosen to go the route of focusing on a compassionate use treatment rather than a vaccine during this time of desperate need.

Good Morning America

Jake appeared on ABC's "Good Morning America" today to talk about our potential COVID-19 cure.

Breakfast

New Zealand news show "Breakfast" invited Jake back on to discuss updates on our work developing the SARS-CoV-2 antibody. Watch the segment here.

PRESS

 

Distributed Bio in the news

Charles River and Distributed Bio Enter Exclusive Partnership to Create an Integrated Antibody Discovery and Development Platform

BUSINESS WIRE | Oct 25, 2018

Distributed Bio's efforts to 

BUSINESS WIRE | Oct 25, 2018

Charles River and Distributed Bio Enter Exclusive Partnership to Create an Integrated Antibody Discovery and Development Platform

BUSINESS WIRE | Oct 25, 2018

Distributed Bio Announces SuperHuman Platform Transfer to Kadmon

BUSINESS WIRE | Feb. 28, 2018

Pfizer, Boehringer sign JLABS resident Distributed Bio’s antibody discovery platform

FIERECE BIOTECH | Jan. 11, 2018

Distributed Bio Announces SuperHuman Platform License Agreement With Pfizer Inc.

BUSINESS WIRE | Jan. 5 2018

Distributed Bio, Inc. and Pandion Therapeutics, Inc. Announce Multi-Target Collaboration

BUSINESS WIRE | Dec. 12, 2017

Distributed Bio and Boehringer Ingelheim Announce SuperHuman Platform Transfer

BUSINESS WIRE | Dec. 11, 2017

VIDEOS

All videos are free to view & download

 

PUBLICATIONS

 

PRESENTATIONS

All presentations are free to view & download

 

SUPERHUMAN 2.0

CARTERRA

PROTEIN ENGINEERING

SUMMIT

IBC TALK 2017

PEGS 2012

THE BETTER BIOLOGIC

PEGS 2013

REPERTOIRE ANALYSIS

& BIOLOGICS OPTIMIZATIONS

NOVEL SEQUENCING TECHNIQUES & COMPUTATIONAL DISCOVERY

CHARACTERIZING HERITABLE VARIATION IN THE ANTIBODY REPERTOIRE

(415) 489-0246

201 Gateway Blvd, Floor 1

 South San Francisco, CA 94080, USA